Karl Heath

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Tanguy Y. Seiwert, Barbara Burtness, Ranee Mehra et al. · The Lancet Oncology · 2016 · 1.7K citations

Medicine, Oncology, Pharmacotherapy +13

Evaluation of Laboratory Methods for Diagnosis of Varicella

Jessica Leung, Rafael Harpaz, Andrew L. Baughman et al. · Clinical Infectious Diseases · 2010 · 128 citations

Veterinary Medicine, Dermatology, Infectious Diseases +17

Pembrolizumab (MK-3475) for advanced urothelial cancer: Updated results and biomarker analysis from KEYNOTE-012.

Elizabeth R. Plimack, Joaquim Bellmunt, Shilpa Gupta et al. · Journal of Clinical Oncology · 2015 · 115 citations

Medicine, Oncology, Urology +17

Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary results from KEYNOTE-012 expansion cohort.

Tanguy Y. Seiwert, Robert I. Haddad, Shilpa Gupta et al. · Journal of Clinical Oncology · 2015 · 103 citations

Medicine, Oncology, Pharmacotherapy +12

Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma:<i>in vitro</i>and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition

Reinhard Dummer, Marc Beyer, Kenneth B. Hymes et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 64 citations

Medicine, Oncology, Pharmacology +14